plateau with semaglutide Weight Loss Plateau: Why It Happens & How to Break Through Semaglutide Weight Loss Plateau: Clinical

MASH GLP-1 first mover

Low Blood Sugar (Hypoglycemia) Wegovy can increase the risk of hypoglycemia, especially when used with other glucose-lowering medications

Semaglutide STEP trials: the benchmark The STEP (Semaglutide Treatment Effect in People with Obesity) trial program established semaglutide as a legitimate weight loss medication

Telehealth Support for Treatment Telehealth offers a practical way to manage treatment schedules for semaglutide and tirzepatide while keeping a close eye on mental health

Of particular note, as someone at the conference asked about the cardiac side effects reported in both trials, the presenters were quick to note the cardiac events were sinus tachycardia, ventricular extrasystoles noted on EKG(aka PVCs, something common and usually of no concern) and a couple patients reporting palpitations

Giugliano D, Scappaticcio L, Longo M, Bellastella G, Esposito K (2021) GLP-1 receptor agonists vs